|

Lidocaine 20mg/ml Clinical Trials

1 actively recruiting trial

Also known as: Lidocaine 2%

Pipeline

Phase 3: 1

Top Sponsors

  • University Health Network, Toronto1

Indications

  • Post-mastectomy Pain Syndrome1
  • Pain, Chronic1
  • Pain, Postoperative1
  • Breast Cancer1
  • Cancer1

Other1 trial

Prevention of Persistent Pain With LidocAine iNfusions in Breast Cancer Surgery (PLAN)
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.